医学
吉西他滨
叶黄素
伊立替康
胰腺癌
肿瘤科
辅助治疗
内科学
癌症
结直肠癌
作者
Thierry Conroy,Pascal Hammel,Mohamed Hebbar,Méher Ben Abdelghani,Alice C. Wei,Jean‐Luc Raoul,Laurence Choné,E. François,Pascal Artru,James Biagi,Thierry Lecomte,Eric Assénat,Roger Faroux,Marc Ychou,Julien Volet,Alain Sauvanet,Gilles Breysacher,Frédéric Di Fiore,C. Cripps,Petr Kavan
标识
DOI:10.1056/nejmoa1809775
摘要
Among patients with metastatic pancreatic cancer, combination chemotherapy with fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) leads to longer overall survival than gemcitabine therapy. We compared the efficacy and safety of a modified FOLFIRINOX regimen with gemcitabine as adjuvant therapy in patients with resected pancreatic cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI